| 摘要 |
The invention relates to the use of compounds of the general Formula (I),and pharmaceutically acceptable acid addition salts for the preparation of pharmaceutical compositions suitable for the reduction of the consequences of acute ischemic or traumatic brain and spinal damages, especially the various types of stroke or cerebral vasospasm, severe brain vessel occlusion, neuronal loss and its functional consequences in the case of head and spinal injuries caused by accidents, or suitable for the treatment of motoneuron disease (ALS), sclerosis multiplex or Creutzfeld Jakob disease. |
